Search Count: 10
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2022-11-30 Classification: CELL CYCLE Ligands: 799 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.46 Å Release Date: 2022-11-30 Classification: CELL CYCLE Ligands: X3W |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.68 Å Release Date: 2022-11-30 Classification: CELL CYCLE Ligands: X3R |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2022-11-30 Classification: CELL CYCLE Ligands: X3N |
 |
Lanthanoid Tagging Via An Unnatural Amino Acid For Protein Structure Characterization
Organism: Homo sapiens
Method: SOLUTION NMR Release Date: 2017-05-31 Classification: PROTEIN BINDING Ligands: TB |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2015-12-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR |
 |
Egfr Kinase (T790M/L858R) With Inhibitor Compound 15: ~{N}-(7-Chloranyl-1~{H}-Indazol-3-Yl)-7,7-Dimethyl-2-(1~{H}-Pyrazol-4-Yl)-5~{H}-Furo[3,4-D]Pyrimidin-4-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2015-12-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 5N3 |
 |
Egfr Kinase (T790M/L858R) With Inhibitor Compound 27: ~{N}-(1~{H}-Indazol-3-Yl)-7,7-Dimethyl-2-(2-Methylpyrazol-3-Yl)-5~{H}-Furo[3,4-D]Pyrimidin-4-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2015-12-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 5N4 |
 |
Crystal Structure Of Nuclear Receptor Subfamily 1, Group H, Member 2 (Lxrb) Complexed With Partial Agonist
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.04 Å Release Date: 2014-12-31 Classification: TRANSCRIPTION/AGONIST Ligands: BU1, 652 |
 |
Discovery Of Xl335, A Highly Potent, Selective And Orally-Active Agonist Of The Farnesoid X Receptor (Fxr)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2009-12-22 Classification: TRANSCRIPTION Ligands: 33Y |